Literature DB >> 9292932

Biotransformations on steroid nucleus of bile acids.

O Bortolini1, A Medici, S Poli.   

Abstract

The bile acids in mammals are all derivatives of 5 beta-cholan-26-oic acid. They represent the major quantitative pathway by which cholesterol is metabolized in the body. This article covers the microbial and enzymatic transformations of free, saturated bile acids, that kept unaltered the C-24 cyclopentane-perhydrophenantrene nucleus. The bile acids that have been considered include the primary cholic and chenodeoxycholic acids, the secondary deoxycholic and lithocholic acids as well as the relevant dehydrocholic, ursocholic and ursodeoxycholic acids. Among the bile acid biotransformations, attention is paid to reactions that lead to pharmaceutically significant compounds. This is the case of 7 alpha-hydroxy epimerization of chenodeoxycholic acid to ursodeoxycholic acid, currently used for cholesterol galistone dissolution therapy and in the treatment of cholestatic liver diseases. Emphasis has placed on reporting reactions that may be of general interest and on the practical aspects of work in the field of biotransformations.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9292932     DOI: 10.1016/s0039-128x(97)00043-3

Source DB:  PubMed          Journal:  Steroids        ISSN: 0039-128X            Impact factor:   2.668


  27 in total

1.  Characterization of cholylglycine hydrolase from a bile-adapted strain of Xanthomonas maltophilia and its application for quantitative hydrolysis of conjugated bile salts.

Authors:  Mariangela Dean; Carlo Cervellati; Elena Casanova; Monica Squerzanti; Vincenzo Lanzara; Alessandro Medici; Patrizia Polverino De Laureto; Carlo M Bergamini
Journal:  Appl Environ Microbiol       Date:  2002-06       Impact factor: 4.792

2.  Genetic analysis of two bile salt hydrolase activities in Lactobacillus acidophilus NCFM.

Authors:  Olivia McAuliffe; Raul J Cano; Todd R Klaenhammer
Journal:  Appl Environ Microbiol       Date:  2005-08       Impact factor: 4.792

3.  Characterization of a novel bile-inducible operon encoding a two-component regulatory system in Lactobacillus acidophilus.

Authors:  Erika A Pfeiler; M Andrea Azcarate-Peril; Todd R Klaenhammer
Journal:  J Bacteriol       Date:  2007-04-20       Impact factor: 3.490

Review 4.  Bile salt hydrolase activity in probiotics.

Authors:  Máire Begley; Colin Hill; Cormac G M Gahan
Journal:  Appl Environ Microbiol       Date:  2006-03       Impact factor: 4.792

5.  Composition of cecal bile acids in ex-germfree mice inoculated with human intestinal bacteria.

Authors:  S Narushima; K Ito; K Kuruma; K Uchida
Journal:  Lipids       Date:  2000-06       Impact factor: 1.880

6.  Two transporters essential for reassimilation of novel cholate metabolites by Rhodococcus jostii RHA1.

Authors:  Kendra Swain; Israël Casabon; Lindsay D Eltis; William W Mohn
Journal:  J Bacteriol       Date:  2012-09-28       Impact factor: 3.490

7.  Bile acids improve the antimicrobial effect of rifaximin.

Authors:  Charles Darkoh; Lenard M Lichtenberger; Nadim Ajami; Elizabeth J Dial; Zhi-Dong Jiang; Herbert L DuPont
Journal:  Antimicrob Agents Chemother       Date:  2010-06-14       Impact factor: 5.191

8.  Degradation of the acyl side chain of the steroid compound cholate in Pseudomonas sp. strain Chol1 proceeds via an aldehyde intermediate.

Authors:  Johannes Holert; Žarko Kulić; Onur Yücel; Vemparthan Suvekbala; Marc J-F Suter; Heiko M Möller; Bodo Philipp
Journal:  J Bacteriol       Date:  2012-11-30       Impact factor: 3.490

9.  Molecular analysis of model gut microbiotas by imaging mass spectrometry and nanodesorption electrospray ionization reveals dietary metabolite transformations.

Authors:  Christopher M Rath; Theodore Alexandrov; Steven K Higginbottom; Jiao Song; Marcos E Milla; Michael A Fischbach; Justin L Sonnenburg; Pieter C Dorrestein
Journal:  Anal Chem       Date:  2012-10-10       Impact factor: 6.986

Review 10.  Intestinal transport and metabolism of bile acids.

Authors:  Paul A Dawson; Saul J Karpen
Journal:  J Lipid Res       Date:  2014-09-10       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.